Sorafenib Monotherapy Versus Sorafenib Combined with Regional Therapies for Hepatocellular Carcinoma Patients with Pulmonary Oligometastases: A Propensity Score-matched Analysis

Background: Sorafenib has been recommended as the standard therapy for advanced HCC with extrahepatic metastasis. The purpose of this retrospective study was to investigate the difference in overall survival (OS) between treatments with sorafenib combined with regional therapies versus sorafenib mon...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cancer
Main Authors: Chen, Jinbin, Lu, Shixun, Zhang, Yaojun, Xu, Li, Chen, Jiancong, Wang, Juncheng, Chen, Minshan, Zhang, Rongxin, Zhou, Zhongguo
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5968762/
https://ncbi.nlm.nih.gov/pubmed/29805700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.24568
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados